Full Text View
Tabular View
No Study Results Posted
Related Studies
TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment
This study has been completed.
Study NCT00164463   Information provided by Centers for Disease Control and Prevention
First Received: September 10, 2005   Last Updated: August 21, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tuberculosis
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Gram-Positive Bacterial Infections
Mycobacterium Infections
Additional drug interventions recognized in this trial
Ethambutol
Moxifloxacin
Pyrazinamide
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antitubercular Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Centers for Disease Control and Prevention
Department of Veterans Affairs
Bayer
National Institutes of Health (NIH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services